Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chow

Showing results (421-430 of 440) with videos related to

Pageof 44
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2021
Clinical Activity of Single-Agent Cabozantinib (XL184), a Multi-receptor Tyrosine Kinase Inhibitor, in Patients with Refractory Soft-Tissue SarcomasGeraldine O'Sullivan Coyne, Shivaani Kummar, James Hu, et al.
Blood|April 19, 2022
Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHLJordan Gauthier, Nicolas Gazeau, Alexandre V Hirayama, et al.
Transplantation and Cellular Therapy|September 27, 2020
Yttrium-90 Anti-CD45 Immunotherapy Followed by Autologous Hematopoietic Cell Transplantation for Relapsed or Refractory LymphomaSherilyn A Tuazon, Ryan D Cassaday, Theodore A Gooley, et al.
Blood Advances|April 30, 2025
Lisocabtagene maraleucel for R/R LBCL in patients not intended for HSCT: final results of the phase 2 PILOT studyAlison Sehgal, Daanish Hoda, Peter A Riedell, et al.
American Journal of Hematology|May 7, 2019
Outcomes of patients with large B-cell lymphomas and progressive disease following CD19-specific CAR T-cell therapyVictor A Chow, Ajay K Gopal, David G Maloney, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2018
Molecular Epidemiology of Candida auris in Colombia Reveals a Highly Related, Countrywide Colonization With Regional Patterns in Amphotericin B ResistancePatricia Escandón, Nancy A Chow, Diego H Caceres, et al.
Mycoses|August 14, 2025
Global Emergence of Antifungal-Resistant Dermatophytosis Caused by Trichophyton indotineae (Formerly T. mentagrophytes ITS Genotype VIII): A Genomic Investigation Involving 14 CountriesAmanda Ribeiro Dos Santos, Silke Uhrlaß, Pietro Nenoff, et al.
Cancer|October 4, 2016
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumorScott M Schuetze, Vanessa Bolejack, Edwin Choy, et al.
Nature Communications|September 8, 2022
Biomarker correlates with response to NY-ESO-1 TCR T cells in patients with synovial sarcomaAlexandra Gyurdieva, Stefan Zajic, Ya-Fang Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2026
Circulating Tumor DNA Assessment of Disease Response in Large B-Cell Lymphoma: Lisocabtagene Maraleucel Versus Autologous Stem Cell Transplantation Standard TherapyLara Stepan, Sahar Ansari, Jeremy S Abramson, et al.
Pageof 44

Showing results (421-430 of 440) with videos related to

Sort By:
Pageof 44
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2021
Clinical Activity of Single-Agent Cabozantinib (XL184), a Multi-receptor Tyrosine Kinase Inhibitor, in Patients with Refractory Soft-Tissue SarcomasGeraldine O'Sullivan Coyne, Shivaani Kummar, James Hu, et al.
Blood|April 19, 2022
Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHLJordan Gauthier, Nicolas Gazeau, Alexandre V Hirayama, et al.
Transplantation and Cellular Therapy|September 27, 2020
Yttrium-90 Anti-CD45 Immunotherapy Followed by Autologous Hematopoietic Cell Transplantation for Relapsed or Refractory LymphomaSherilyn A Tuazon, Ryan D Cassaday, Theodore A Gooley, et al.
Blood Advances|April 30, 2025
Lisocabtagene maraleucel for R/R LBCL in patients not intended for HSCT: final results of the phase 2 PILOT studyAlison Sehgal, Daanish Hoda, Peter A Riedell, et al.
American Journal of Hematology|May 7, 2019
Outcomes of patients with large B-cell lymphomas and progressive disease following CD19-specific CAR T-cell therapyVictor A Chow, Ajay K Gopal, David G Maloney, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2018
Molecular Epidemiology of Candida auris in Colombia Reveals a Highly Related, Countrywide Colonization With Regional Patterns in Amphotericin B ResistancePatricia Escandón, Nancy A Chow, Diego H Caceres, et al.
Mycoses|August 14, 2025
Global Emergence of Antifungal-Resistant Dermatophytosis Caused by Trichophyton indotineae (Formerly T. mentagrophytes ITS Genotype VIII): A Genomic Investigation Involving 14 CountriesAmanda Ribeiro Dos Santos, Silke Uhrlaß, Pietro Nenoff, et al.
Cancer|October 4, 2016
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumorScott M Schuetze, Vanessa Bolejack, Edwin Choy, et al.
Nature Communications|September 8, 2022
Biomarker correlates with response to NY-ESO-1 TCR T cells in patients with synovial sarcomaAlexandra Gyurdieva, Stefan Zajic, Ya-Fang Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2026
Circulating Tumor DNA Assessment of Disease Response in Large B-Cell Lymphoma: Lisocabtagene Maraleucel Versus Autologous Stem Cell Transplantation Standard TherapyLara Stepan, Sahar Ansari, Jeremy S Abramson, et al.
Pageof 44